home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

30.04 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 29, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Capricor Therapeutics, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Hewlett Packard Enterprise, Nvidia, Progress Software And Other Big Stocks Moving Higher On Wednesday ↗

September 25, 2024

Via Benzinga

Nvidia, Alibaba, Capricor Therapeutics, TSMC, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

September 24, 2024

On Tuesday, major U.S. indices closed higher, with the Dow Jones Industrial Average gaining 0.2% to reach 42,208.22.

Via Benzinga

Topics Stocks

Why Capricor Therapeutics Stock Is Soaring Tuesday ↗

September 24, 2024

Capricor Therapeutics Inc (NASDAQ:CAPR) shares are trading higher Tuesday after the company announced intent to file a biologics license application (BLA) for the full approval of Deramiocel for the...

Via Benzinga

Week In Review: Nippon Shinyaku Signs $735 Million Deal For DMD Therapy ↗

September 21, 2024

Japan’s Nippon Shinyaku will acquire European rights for a Duchenne muscular dystrophy disease therapy developed by Capricor Therapeutics of San Diego. Nippon Shinyaku will pay $20 million upfront and...

Via Talk Markets

Deep Dive Into Capricor Therapeutics Stock: Analyst Perspectives (5 Ratings) ↗

September 20, 2024

Via Benzinga

Unveiling 6 Analyst Insights On Capricor Therapeutics ↗

July 02, 2024

Via Benzinga

What's Going On With Capricor Therapeutics Stock Friday? ↗

June 28, 2024

The biotechnology company said deramiocel increased cardiac function based on several different measures.

Via Benzinga

Expert Ratings For Capricor Therapeutics ↗

May 14, 2024

Via Benzinga

EXCLUSIVE: Capricor Therapeutics Inks European Expansion, Commercialization Pact For Lead Asset With Japanese Pharma Firm ↗

September 17, 2024

Capricor Therapeutics partners with Nippon Shinyaku for the European commercialization of Duchenne muscular dystrophy treatment, deramiocel, with a potential $1.5 billion in milestone payments from...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 11, 2024

Via Benzinga

What's Going On With Capricor Therapeutics Stock Tuesday? ↗

June 11, 2024

Capricor Therapeutics announced successful completion of a Type-B meeting with the U.S. Food and Drug Administration (FDA).

Via Benzinga

What's Going On With Capricor Therapeutics Stock Tuesday? ↗

June 04, 2024

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is trading higher Tuesday after the company announced three-year results from the ongoing HOPE-2 open-label extension

Via Benzinga

CAPR Stock Earnings: Capricor Therapeutics Misses EPS, Misses Revenue for Q1 2024 ↗

May 13, 2024

CAPR stock results show that Capricor Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

Recap: Capricor Therapeutics Q4 Earnings ↗

February 29, 2024

Via Benzinga

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

Capricor Therapeutics's Earnings Outlook ↗

February 28, 2024

Via Benzinga

Preview: Capricor Therapeutics's Earnings ↗

November 13, 2023

Via Benzinga

Recap: Capricor Therapeutics Q1 Earnings ↗

May 11, 2023

Via Benzinga

FlexShopper And 3 Other Penny Stocks Insiders Are Buying ↗

October 12, 2023

The Dow Jones closed higher by around 65 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying ↗

October 09, 2023

The Dow Jones closed higher by around 290 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

US Stocks Turn Lower; Dow Tumbles Over 200 Points ↗

September 29, 2023

U.S. stocks turned lower toward the end of trading, with the Dow Jones falling over 200 points on Friday. The Dow traded down 0.70% to 33,432.17 while the NASDAQ fell 0.15% to 13,181.22. The S&P 500...

Via Benzinga

Topics Stocks

Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

September 29, 2023

Gainers Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share.

Via Benzinga

Earnings Preview For Capricor Therapeutics ↗

March 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 29, 2023

Via Benzinga

Crude Oil Down 1% Following PCE Data; Blue Apron Shares Surge ↗

September 29, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Friday. The Dow traded up 0.13% to 33,710.74 while the NASDAQ rose 0.99% to 13,331.54. The S&P 500...

Via Benzinga

Topics Stocks

Nasdaq Gains Over 1%; Nike Posts Upbeat Earnings ↗

September 29, 2023

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 1% on Friday. The Dow traded up 0.24% to 33,746.70 while the NASDAQ rose 1.22% to 13,362.51. The S&P 500 also rose,...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 29, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 29, 2023

Via Benzinga

Top 5 Health Care Stocks That May Fall Off A Cliff ↗

August 23, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Earnings Scheduled For March 15, 2023 ↗

March 15, 2023

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com